Inventor · disambiguated record
Kay Olmstead
Also filed as: OLMSTEAD KAY · OLMSTEAD KAY K
16 granted patents·25 pending applications·49 citations·filing 2003–2025
91Inventor score
Files withSANTARUS INC12INTERCEPT PHARMACEUTICALS INC8MINGSIGHT PHARMACEUTICALS INC4NOVMETAPHARMA CO LTD4NANO PHARMASOLUTIONS INC3
Top patents by PatentIndex Score
41 records- 0193US10052337B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 21, 2018·21 cites·19 claims
- 0287US10758549B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted Sep 1, 2020·2 cites·33 claims
- 0386US10683300B2Polymorphic forms of Cyclo (-His-Pro)NOVMETAPHARMA CO LTD·Filed 2019·Granted Jun 16, 2020·5 cites·28 claims
- 0485US8993599B2Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using themHALL WARREN·Filed 2006·Granted Mar 31, 2015·8 cites·32 claims
- 0584US9320738B2Formulations of 5-fluorocytosine and uses thereofGRUBER HARRY E·Filed 2009·Granted Apr 26, 2016·5 cites·68 claims
- 0683US10646499B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted May 12, 2020·1 cites·20 claims
- 0780US11820834B2Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney diseaseNOVMETAPHARMA CO LTD·Filed 2020·Granted Nov 21, 2023·1 cites·15 claims
- 0880US8815916B2Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using themOLMSTEAD KAY·Filed 2005·Granted Aug 26, 2014·3 cites·11 claims
- 0980US2025388588A1Pkc inhibitor solid state formsMINGSIGHT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1079US12370145B2Therapeutic agent nanoparticles and methods of preparationNANO PHARMASOLUTIONS INC·Filed 2021·Granted Jul 29, 2025·1 cites·19 claims
- 1176US11191764B2Formulations of 5-fluorocytosine and uses thereofDENOVO BIOPHARMA LLC·Filed 2019·Granted Dec 7, 2021·0 cites·18 claims
- 1275US2022133745A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1374US10751349B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·0 cites·22 claims
- 1474US9889133B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2016·Granted Feb 13, 2018·1 cites·18 claims
- 1573US8906940B2Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using themOLMSTEAD KAY·Filed 2005·Granted Dec 9, 2014·1 cites·22 claims
- 1671US12415807B2PKC inhibitor solid state formsMINGSIGHT PHARMACEUTICALS INC·Filed 2021·Granted Sep 16, 2025·0 cites·15 claims
- 1769US2022133778A1Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using themSANTARUS INC·Filed 2021·Application pending·0 cites
- 1867US2020046736A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1967US2020046735A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2067US2020054650A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2166US2015044303A1Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using ThemSANTARUS INC·Filed 2014·Application pending·0 cites
- 2265US2023310321A1Therapeutic agent nanoparticles and methods of preparationNANO PHARMASOLUTIONS INC·Filed 2023·Application pending·0 cites
- 2365US2019022131A1Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using themSANTARUS INC·Filed 2018·Application pending·0 cites
- 2463US10449194B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2018·Granted Oct 22, 2019·0 cites·13 claims
- 2560US11104679B2PKC inhibitor solid state formsMINGSIGHT PHARMACEUTICALS INC·Filed 2018·Granted Aug 31, 2021·0 cites·13 claims
- 2654US2014370104A1Pharmaceutical formulation and method for treating acid caused gastrointestinal disordersSANTARUS INC·Filed 2014·Application pending·0 cites
- 2753US2005037070A1Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using themSANTARUS INC·Filed 2004·Application pending·0 cites
- 2853US2005031700A1Pharmaceutical formulation and method for treating acid-caused gastrointestinal disordersSANATARUS INC·Filed 2004·Application pending·0 cites
- 2950US2023028918A1Compositions comprising pkc-beta inhibitors and processes for the preparation thereofMINGSIGHT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3050US2024000717A1Dry powder antiviral compositions and their use for treating viral infectionNANO PHARMASOLUTIONS INC·Filed 2021·Application pending·0 cites
- 3149US2015202226A1Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using themSANTARUS INC·Filed 2015·Application pending·0 cites
- 3247US2010297220A1Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal DisordersSANTARUS INC·Filed 2010·Application pending·0 cites
- 3346US2008268045A1Sustained release methotrexate formulations and methods of use thereofPROPRIUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3445US2009092658A1Novel formulations of proton pump inhibitors and methods of using these formulationsSANTARUS INC·Filed 2007·Application pending·0 cites
- 3544US2021401880A1Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active IngredientNOVMETAPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 3643US2014271853A1Novel formulations of proton pump inhibitors and methods of using these formulationsSANTARUS INC·Filed 2014·Application pending·0 cites
- 3743US2005239845A1Combination of proton pump inhibitor, buffering agent, and prokinetic agentSANTARUS INC·Filed 2005·Application pending·0 cites
- 3842US2005244517A1Combination of proton pump inhibitor and sleep aidSANTARUS INC·Filed 2004·Application pending·0 cites
- 3942US2021100872A1Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes MellitusNOVMETAPHARMA CO LTD·Filed 2018·Application pending·0 cites
- 4041US2004006111A1Transmucosal delivery of proton pump inhibitorsFiled 2003·Application pending·0 cites
- 4136US2005249806A1Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drugSANTARUS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kay Olmstead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →